Careers  |  Sign In  |  Register  |   Twitter

Latest in Internal Medicine

Individualizing testing may be just as important as individualizing treatment.
What if we could predict if a patient's lung cancer would recur using a simple blood test?
Joseph Vassalotti, MD, Chief Medical Officer of the National Kidney Foundation, wants to remind physicians that urine testing to measure the albumin-to-creatinine ratio (ACR) isn’t done as frequently as it should be in people at risk for chronic kidney disease (CKD), such as patients with diabetes and...